The pharmaceutical industry has consistently produced a trade surplus, totalling £3 billion in 2014, and is responsible for 25% of the total expenditure on research and development by UK businesses.1,2
In addition to benefiting the UK economy, the pharmaceutical industry also delivers improved health outcomes for patients. But, tackling contemporary challenges such as an ageing population, which fundamentally impacts the healthcare landscape, will require further research efforts.
Companies involved in all aspects of the development and manufacture of pharmaceutical products can invest in technologies to increase productivity and efficiency. For instance, in the manufacturing process, improved technologies can help to reduce waste and increase speed of production.3
Not yet a Subscriber?
This is a small extract of the full article which is available ONLY to premium content subscribers. Click below to get premium content on Manufacturing Chemist.
Subscribe now Already a subscriber? Sign in here.